Century Therapeutics, Inc. (IPSC) Operating cash flow 2020–2025
Century Therapeutics, Inc. (IPSC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$103.9MFY2025 · since FY2020: -$41.3M → -$103.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$103.9M | +5.7% |
| FY2024 | -$110.1M | -24.7% |
| FY2023 | -$88.3M | -728.7% |
| FY2022 | $14.1M | +115.8% |
| FY2021 | -$89.0M | -115.7% |
| FY2020 | -$41.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IPSC financial trends
IPSC RevenueIPSC Net incomeIPSC Net marginIPSC Gross profitIPSC Gross marginIPSC Operating incomeIPSC Operating marginIPSC Free cash flowIPSC Capital expendituresIPSC Return on equityIPSC Stock buybacksIPSC Dividends paidIPSC Total assetsIPSC Total liabilitiesIPSC Shareholders’ equityIPSC overview →